logo
Plus   Neg
Share
Email

Alexion Boosts FY19 Outlook - Quick Facts

While reporting financial results for the second quarter, Alexion Pharmaceuticals, Inc. (ALXN) on Wednesday raised its adjusted earnings and revenue guidance for the full year 2019 to reflect strength of the business and continued growth.

For fiscal 2019, the company now projects earnings in a range of $8.13 to $8.41 per share and adjusted earnings in a range of $9.65 to $9.85 per share on total revenues between $4.75 billion and $4.80 billion.

Previously, the company projected earnings in a range of $6.76 to $7.96 per share and adjusted earnings in a range of $9.25 to $9.45 per share on total revenues between $4.675 billion and $4.75 billion.

On average, analysts polled by Thomson Reuters expect earnings of $9.44 per share on revenues of $4.78 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Toyota Motor Corp. (TM) announced plans to invest $391 million at its pickup truck assembly plant in San Antonio, Texas. The investment is part of the Japanese automaker's plan to invest $13 billion in its U.S. operations over five years through 2021. The company said the investment will be used... Virgin Atlantic is set to challenge British Airways' dominance at London Heathrow as the carrier announced plans to fly to 84 new destinations from the airport when its third runway is opened. Chief Executive Shai Weiss said, "Heathrow has been dominated by one airline group for far too long. The... Walmart (WMT) on Wednesday announced that it is teaming up with Capital One to roll out two new credit cards designed to compete with cards from Apple and Amazon. The companies said the Capital One Walmart Rewards Credit Card Program with two new cards will launch on September 24. The program's Mastercard...
Follow RTT